Login / Signup

COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis.

Rikke Boedker HolmstroemOle Haagen NielsenSøren JacobsenLene Buhl RiisSusann TheileJacob Tveiten BjerrumPeter VilmannJulia Sidenius JohansenMogens Karsbøl BoisenRikke Helene Løvendahl EefsenInge Marie SvaneDorte Lisbet NielsenInna Markovna Chen
Published in: Journal for immunotherapy of cancer (2022)
NCT03601611.
Keyphrases
  • open label
  • rheumatoid arthritis
  • clinical trial
  • juvenile idiopathic arthritis
  • study protocol
  • squamous cell carcinoma
  • rheumatoid arthritis patients
  • systemic lupus erythematosus
  • radiation therapy